Yahoo
NasdaqGS - Nasdaq Real Time Price USD

ICU Medical, Inc. (ICUI)

143.22 +0.80 (+0.57%)
As of 9:42:10 AM EDT. Market Open.
Trade ICUI on Coinbase
Chart Range Bar
Loading chart for ICUI
  • Previous Close 142.41
  • Open 142.59
  • Bid 142.45 x 100
  • Ask 184.30 x 200
  • Day's Range 140.72 - 143.44
  • 52 Week Range 107.00 - 160.29
  • Volume 4,782
  • Avg. Volume 286,638
  • Market Cap (intraday) 3.579B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) 76.59
  • EPS (TTM) 1.87
  • Earnings Date (est.) Aug 6, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 172.50

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

www.icumed.com

13,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 6/17/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ICUI
0.38%
S&P 500 (^GSPC)
9.93%

1-Year Return

ICUI
10.19%
S&P 500 (^GSPC)
25.78%

3-Year Return

ICUI
24.20%
S&P 500 (^GSPC)
70.65%

5-Year Return

ICUI
30.26%
S&P 500 (^GSPC)
78.24%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 525.77M
Earnings 50.19M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
100M
200M
300M
400M
500M

Analyst Insights

View More

Analyst Price Targets

160.00
172.50 Average
143.21 Current
200.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/15/2026
Analyst BTIG
Rating Action Initiated
Rating Buy
Price Action Announces
Price Target 170

Statistics

View More

Valuation Measures

Annual
As of 6/16/2026
  • Market Cap

    3.56B

  • Enterprise Value

    4.60B

  • Trailing P/E

    76.60

  • Forward P/E

    17.45

  • PEG Ratio (5yr expected)

    0.08

  • Price/Sales (ttm)

    1.66

  • Price/Book (mrq)

    1.69

  • Enterprise Value/Revenue

    2.13

  • Enterprise Value/EBITDA

    15.37

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.15%

  • Return on Assets (ttm)

    1.68%

  • Return on Equity (ttm)

    2.26%

  • Revenue (ttm)

    2.16B

  • Net Income Avi to Common (ttm)

    46.34M

  • Diluted EPS (ttm)

    1.87

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    292.68M

  • Total Debt/Equity (mrq)

    63.62%

  • Levered Free Cash Flow (ttm)

    387.08M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

143.21 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Raising target price to $149.00

    ICU MEDICAL INC has an Investment Rating of HOLD; a target price of $149.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • Lowering target price to $124.00

    ICU MEDICAL INC has an Investment Rating of HOLD; a target price of $124.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • Raising target price to $142.00

    ICU MEDICAL INC has an Investment Rating of HOLD; a target price of $142.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • What does Argus have to say about ICUI?

    ICU MEDICAL INC has an Investment Rating of HOLD; a target price of $117.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: